Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2

BACKGROUND: Cholangiocarcinoma (CCA) represents the epithelial cell cancer with high aggressiveness whose five-year survival rate is poor with standard treatment. Calcyclin-binding protein (CACYBP) shows aberrant expression within several malignant tumors, but the role of CACYBP in CCA remains unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, YUSEN, LIU, LIPING, LUO, BIWEI, TANG, HONGGUI, YU, XIAOFANG, BAO, SHIYUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229312/
https://www.ncbi.nlm.nih.gov/pubmed/37305391
http://dx.doi.org/10.32604/or.2023.028418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229312/
https://www.ncbi.nlm.nih.gov/pubmed/37305391
http://dx.doi.org/10.32604/or.2023.028418

Ejemplares similares